Longevity VC market expected to grow from $8.5B in 2024 to $12-18B in 2026.

Longevity VC market expected to grow from $8.5B in 2024 to $12-18B in 2026. | longevity startups raised 8.5 billion in 2024. That's expected to grow to somewhere between 12 to 18 billion this year. Uh roughly a doubling of the longevity venture market investments.

Watch events: Life Biosciences ER-100 Phase 1 first readout (likely late 2026/early 2027)

longevity startups raised 8.5 billion in 2024. That's expected to grow to somewhere between 12 to 18 billion this year. Uh roughly a doubling of the longevity venture market investments.

Beneficiaries (19)

Adverse (4)

{
  "nia": false,
  "qty": "$12-18B",
  "url": "https://www.youtube.com/watch?v=T8X6kp-pcKs",
  "mode": "FORECAST",
  "role": "Host",
  "context": "longevity startups raised 8.5 billion in 2024. That's expected to grow to somewhere between 12 to 18 billion this year. Uh roughly a doubling of the longevity venture market investments.",
  "to_year": 2026,
  "verbatim": "longevity startups raised 8.5 billion in 2024. That's expected to grow to somewhere between 12 to 18 billion this year. Uh roughly a doubling of the longevity venture market investments.",
  "conv_cues": "expected to",
  "direction": "NUMERIC_TARGET",
  "from_year": 2026,
  "timeframe": "2026",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "overdue",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2026-02-26",
      "observed_date": null,
      "miss_emitted_at": "2026-05-02T22:07:21.384228+00:00",
      "miss_emitted_by": "metadata_milestone_sweep"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q2 window check-in (50%)",
      "status": "overdue",
      "weight": 0.05,
      "ordinal": -5,
      "source_id": null,
      "expected_date": "2026-04-23",
      "observed_date": null,
      "miss_emitted_at": "2026-05-02T22:07:21.384228+00:00",
      "miss_emitted_by": "metadata_milestone_sweep"
    },
    {
      "kind": "llm_pre_event",
      "label": "Q1 2026 Q1 funding alone reaches ~$1.94B aggregate",
      "notes": "HIT — 18 disclosed rounds Q1 2025 to Q1 2026 totaled ~$1.94B per NewMarketPitch tracker.",
      "source": "https://newmarketpitch.com/blogs/news/longevity-funding-deals",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -4,
      "source_id": null,
      "confidence": 0.95,
      "source_url": "https://newmarketpitch.com/blogs/news/longevity-funding-deals",
      "expected_date": "2026-04-30",
      "observed_date": "2026-04-30",
      "research_origin": "deep_research",
      "measurement_criterion": "Industry trackers (NewMarketPitch, PitchBook) report Q1 2026 longevity round total approaching $2B"
    },
    {
      "kind": "llm_pre_event",
      "label": "Mega-round (>=$200M) in longevity therapeutics announced in 2026",
      "source": "https://newmarketpitch.com/blogs/news/longevity-funding-deals",
      "status": "overdue",
      "weight": 0.4,
      "ordinal": -3,
      "source_id": null,
      "confidence": 0.85,
      "source_url": "https://newmarketpitch.com/blogs/news/longevity-funding-deals",
      "expected_date": "2026-05-17",
      "miss_emitted_at": "2026-05-30T22:15:00.756418+00:00",
      "miss_emitted_by": "metadata_milestone_sweep",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2026-09-30",
        "from": "2026-01-01"
      },
      "measurement_criterion": "At least one longevity therapeutics company announces a single round of >=$200M in 2026 (e.g., Retro, NewLimit, Function Health follow-on)"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q3 window check-in (75%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -2,
      "source_id": null,
      "expected_date": "2026-06-18",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Q1 2026 longevity funding rounds disclose mid-year totals",
      "source": "https://news.crunchbase.com/venture/longevity-startup-funding-2025-newlimit-data/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -1,
      "source_id": null,
      "confidence": 0.7,
      "source_url": "https://news.crunchbase.com/venture/longevity-startup-funding-2025-newlimit-data/",
      "expected_date": "2026-07-31",
      "research_origin": "deep_research",
      "measurement_criterion": "Aggregate longevity startup funding for H1 2026 disclosed by Crunchbase/PitchBook reaches >=$6B (on track for $12-18B annual)"
   
... (truncated)